In vitro activity of beta-lactam antibiotics to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

C Germel, A Haag, B Söderquist
Author Information
  1. C Germel: Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, SE-70185, Örebro, Sweden.

Abstract

Community-associated (CA) MRSA often display low MIC values against oxacillin. The in vitro activity of various beta-lactam antibiotics against heterogeneous CA-MRSA (n = 98) isolated in a low endemic area was determined by Etest, and Mueller-Hinton agar (MUHAP) was compared with Mueller-Hinton agar supplemented with 2% NaCl (MUHSP). In general, the CA-MRSA isolates showed higher MIC values for the various beta-lactam antibiotics on MUHSP compared with MUHAP. MIC values for oxacillin ranged from 1 to >256 mg/L on MUHSP. Cephalothin, representing the first generation of cephalosporins, showed MICs from 0.75 to 96 mg/L and the MIC(50) and MIC(90) for cefuroxime, cefotaxime and cefepime, representing the second, third and fourth generations, respectively, were rather high. However, the MIC(50) and MIC(90) for ceftobiprole (fifth generation) were 1.5 and 2 mg/L, respectively, on MUHSP. The MIC(50) and MIC(90) for imipenem were 0.75 and 2 mg/L, respectively, on MUHSP. Only 3/98 (3%) CA-MRSA isolates showed a MIC >4 mg/L. Consequently, low MIC values for imipenem, lower than those of the newly developed fifth generation cephalosporins, were found among CA-MRSA. These findings may be considered for further studies including clinical trials in order to evaluate carbapenems as a potential treatment option for infections caused by CA-MRSA.

References

  1. Antimicrob Agents Chemother. 2005 Oct;49(10):4210-9 [PMID: 16189100]
  2. Antimicrob Agents Chemother. 2009 Dec;53(12):4961-7 [PMID: 19721075]
  3. Clin Microbiol Infect. 2005 Dec;11(12):1027-34 [PMID: 16307559]
  4. J Clin Microbiol. 2006 Dec;44(12):4395-9 [PMID: 17050809]
  5. Antimicrob Agents Chemother. 2001 May;45(5):1323-36 [PMID: 11302791]
  6. Clin Microbiol Infect. 2005 Jun;11(6):447-56 [PMID: 15882194]
  7. Lancet Infect Dis. 2010 Apr;10(4):227-39 [PMID: 20334846]
  8. J Clin Microbiol. 2005 Sep;43(9):4448-54 [PMID: 16145090]
  9. Antimicrob Agents Chemother. 2008 Aug;52(8):2849-54 [PMID: 18519723]
  10. J Infect Chemother. 2009 Feb;15(1):54-7 [PMID: 19280303]
  11. Antimicrob Agents Chemother. 2002 Apr;46(4):1147-52 [PMID: 11897611]
  12. Emerg Infect Dis. 2001 Mar-Apr;7(2):178-82 [PMID: 11294701]
  13. Antimicrob Agents Chemother. 2008 Aug;52(8):2974-6 [PMID: 18519721]
  14. J Clin Invest. 2009 Sep;119(9):2464-74 [PMID: 19729844]

MeSH Term

Anti-Bacterial Agents
Community-Acquired Infections
Humans
Methicillin-Resistant Staphylococcus aureus
Microbial Sensitivity Tests
Staphylococcal Infections
beta-Lactams

Chemicals

Anti-Bacterial Agents
beta-Lactams

Word Cloud

Created with Highcharts 10.0.0MICCA-MRSAMUHSPvalueslowbeta-lactamantibioticsshowedgeneration5090respectivelyoxacillinvitroactivityvariousMueller-HintonagarMUHAPcomparedisolates1representingcephalosporins075fifth2 mg/LimipenemCommunity-associatedCAMRSAoftendisplayheterogeneousn = 98isolatedendemicareadeterminedEtestsupplemented2%NaClgeneralhigherranged>256 mg/LCephalothinfirstMICs96 mg/LcefuroximecefotaximecefepimesecondthirdfourthgenerationsratherhighHoweverceftobiprole53/983%>4 mg/LConsequentlylowernewlydevelopedfoundamongfindingsmayconsideredstudiesincludingclinicaltrialsorderevaluatecarbapenemspotentialtreatmentoptioninfectionscausedcommunity-associatedmethicillin-resistantStaphylococcusaureus

Similar Articles

Cited By